ArticleOncoimmunology2022
A first-in-class, non-invasive, immunodynamic biomarker approach for precision immuno-oncology.
Jenny Sprooten et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
this papercites it
ArticleOncoimmunology2022
Jenny Sprooten et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.